Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Apple ( AAPL - Analyst Report ) was able to beat earnings estimates in its fiscal first quarter following two consecutive misses, but everything else about the company’s performance was lackluster at best. The revenue result fell short of expectations as iPhone sales were soft.
As a result, shares of AAPL were down more than 6% in the after hours.
The report was certainly not a disaster for this influential tech company, but it wasn’t the turnaround that people were hoping for. Strong reports from IBM and Google yesterday had the market preparing for another good performance from the biggest bellwether in the industry. Now, we’re left to wonder what kind of an impact this will have on earnings season, which has been moving along at a decent, though not spectacular, pace thus far.
Apple reported fiscal first quarter earnings per share of $13.81, which was nearly 3% better than the Zacks Consensus Estimate at $13.44. It was flat from last year’s $13.87, but improved upon negative surprises of 2.03% in last year’s fiscal fourth quarter and nearly 10% in the fiscal third quarter.
The problem was on the top line. Revenue of $54.5 billion was a record and more than 17% better on a year-over-year basis. However, it missed the Zacks Consensus Estimate at $54.8 billion. It was a very slight miss, but a miss nonetheless for a company that once left such expectations in the dust.
The biggest disappointment though was the all-important iPhones. It shipped 47.8 million of them in the quarter, which was less than expected. Sales of the iPad were in line with expectations. Apple may still be the biggest growth story over the long term, but it is obviously facing more, and better, competition than ever before.
Quite frankly, Apple probably needed a better quarter than this to get back on track. Shares of the company are down approximately 30% from its peak, and reached a nearly 52-week low last week. Furthermore, it is a Zacks Rank #3 (Hold). The past 60 days have seen 18 of 39 earnings estimates for this fiscal year move lower, while only 2 were revised higher.
We’ll have a lot more of this company’s report and its impact on the market coming up….
Read the full reports :
Analyst Report on AAPL